Kiran Mazumdar-Shaw

Insider Reports History

Entity
Individual
Location
Bicara Therapeutics Inc., 116 Huntington Avenue, Suite 703, Boston, MA
Signature
/s/ Lara Meisner, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kiran Mazumdar-Shaw:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Bicara Therapeutics Inc. Director, 10%+ Owner Common Stock 4.44M Sep 16, 2024 By Biocon Limited
Bicara Therapeutics Inc. Director, 10%+ Owner Common Stock 1.08M Sep 16, 2024 By Biocon Pharma Inc.
Bicara Therapeutics Inc. Director, 10%+ Owner Common Stock 433K Sep 16, 2024 By Carica Investments
Bicara Therapeutics Inc. Director, 10%+ Owner Common Stock 325K Sep 16, 2024 By Glentech International
Bicara Therapeutics Inc. Director, 10%+ Owner Stock Option (Right to Buy) 23.7K Sep 12, 2024 Direct
Bicara Therapeutics Inc. Director, 10%+ Owner Series Seed Redeemable Convertible Preferred Stock 0 Sep 16, 2024 By Biocon Limited
Bicara Therapeutics Inc. Director, 10%+ Owner Series Seed Redeemable Convertible Preferred Stock 0 Sep 16, 2024 By Biocon Pharma Inc.
Bicara Therapeutics Inc. Director, 10%+ Owner Series Seed Redeemable Convertible Preferred Stock 0 Sep 16, 2024 By Carica Investments
Bicara Therapeutics Inc. Director, 10%+ Owner Series Seed Redeemable Convertible Preferred Stock 0 Sep 16, 2024 By Glentech International

Insider Reports Filed by Kiran Mazumdar-Shaw

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BCAX Bicara Therapeutics Inc. Sep 12, 2024 9 $0 4 Sep 16, 2024 Director, 10%+ Owner
BCAX Bicara Therapeutics Inc. Sep 12, 2024 0 $0 3 Sep 12, 2024 Director, 10%+ Owner